Moneycontrol
Last Updated : Jan 30, 2018 02:41 PM IST | Source: CNBC-TV18

Expect 10-15% growth in FY18: Suven Life Sciences

In an interview with CNBC-TV18, Venkat Jasti, Chairman and CEO at Suven Life Sciences discussed Q3 results and his outlook for the company.

CNBC TV18 @moneycontrolcom

In an interview with CNBC-TV18, Venkat Jasti, Chairman and CEO at Suven Life Sciences discussed Q3 results and his outlook for the company.

Pipeline for Contract research and manufacturing services (CRAMS) business is looking good and we have about 114 active projects on hand, he said.

Expect 10-15 percent growth in FY18, he added.

For full interview, watch accompanying video...
First Published on Jan 30, 2018 02:41 pm
Sections
Follow us on
Available On